epidemiolog
studi
uncov
strong
associ
viral
infect
especi
caus
rhinoviru
exacerb
asthma
attack
howev
mechan
virus
induc
exacerb
chronic
airway
diseas
well
understood
respons
viral
infect
airway
epithelium
lesser
extent
immun
cell
monocyt
macrophag
dendrit
cell
releas
proinflammatori
cytokin
interferon
ifn
antimicrobi
substanc
turn
promot
clearanc
microorgan
activ
adapt
immun
system
howev
patient
chronic
respiratori
ill
innat
immun
respons
may
also
respons
diseas
exacerb
although
inflammatori
respons
experiment
rhinoviru
infect
monitor
studi
examin
innat
immun
respons
patient
asthma
natur
cold
increas
respiratori
tract
detect
examin
innat
immun
respons
viral
infect
children
asthma
measur
nasal
aspir
cytokin
level
asthmat
children
upper
respiratori
tract
infect
contrast
previou
studi
examin
least
three
time
point
associ
symptomat
ill
evalu
associ
viral
infect
cytokin
express
cytokin
express
symptom
score
also
examin
effect
upper
respiratori
tract
infect
mrna
level
select
marker
viral
infect
includ
ifn
final
evalu
new
method
viru
detect
use
singl
polymeras
chain
reactionlig
detect
reaction
pcrldr
multiplex
assay
hypothes
respiratori
viral
infect
children
asthma
caus
robust
elabor
proinflammatori
cytokin
ifn
level
proinflammatori
cytokin
correl
symptom
sever
conduct
observ
cohort
studi
children
asthma
children
elig
studi
receiv
care
univers
michigan
physician
asthma
age
year
live
within
mile
radiu
ann
arbor
outpati
enrol
month
goal
assess
cytokin
baselin
associ
least
one
viralinduc
exacerb
period
initi
consent
first
evalu
conduct
univers
michigan
subsequ
evalu
perform
particip
home
studi
approv
univers
michigan
institut
review
board
approv
number
clinic
investig
conduct
accord
principl
express
declar
helsinki
http
wwwwmanet
initi
assess
parent
guardian
complet
extens
questionnair
includ
standard
question
presenc
frequenc
asthma
symptom
inventori
child
asthma
medic
current
usag
queri
environment
exposur
child
famili
demograph
inform
baselin
asthma
sever
assess
use
nation
asthma
educ
prevent
program
guidelin
incorpor
adjust
asthma
control
therapi
use
perform
home
measur
respiratori
symptom
collect
nasal
secret
detect
viral
rna
pcr
host
biomark
pcr
elisa
day
week
children
healthi
report
upper
respiratori
tract
infect
asthma
symptom
week
experienc
cold
flulik
symptom
famili
given
calendar
simpl
respiratori
symptom
scale
ask
mark
level
symptom
use
modifi
version
respiratori
symptom
score
develop
child
origin
asthma
studi
assess
fever
cough
nasal
symptom
wheez
difficulti
breath
wake
night
cough
interfer
usual
activ
patient
experienc
symptomat
respiratori
ill
defin
symptom
score
two
higher
scale
famili
notifi
studi
staff
schedul
visit
within
h
begin
symptom
defin
day
ill
inform
regard
impact
respiratori
symptom
daili
activ
recent
use
asthma
medicin
also
collect
note
studi
technician
visit
home
everi
day
retriev
addit
nasal
wash
sampl
total
three
visit
week
follow
report
symptom
three
specif
day
week
select
analysi
base
conveni
subject
laboratori
technician
although
specimen
often
collect
day
given
week
specimen
collect
sometim
compress
period
collect
nasal
lavag
sampl
util
protocol
develop
powel
shorr
modifi
jame
gern
univers
wisconsin
person
commun
two
squirt
isoton
sodium
chlorid
instil
child
nostril
estim
ml
per
nostril
use
commerci
avail
nasal
salin
spray
bf
ascher
lenexa
ks
usa
subject
blew
nose
zipper
plastic
bag
ml
viral
transport
medium
remel
lenexa
ks
usa
ad
gener
sampl
collect
presenc
studi
staff
transport
home
laboratori
within
h
collect
cooler
ice
pack
howev
due
logist
issu
schedul
home
visit
famili
also
provid
kit
independ
collect
nasal
wash
specimen
home
visit
could
schedul
within
h
famili
instruct
collect
sampl
doubl
bag
sampl
place
tightli
seal
collect
box
keep
refriger
staff
could
collect
sampl
requir
week
interv
sampl
collect
sequenti
ill
nasal
aspir
homogen
use
handheld
homogen
allow
pipet
viscou
sampl
frozen
allow
batch
analysi
viral
rna
dna
extract
use
minelut
kit
qiagen
valencia
ca
usa
sampl
assess
presenc
viral
rna
dna
via
pcr
use
seegen
seeplex
detect
kit
seegen
rockvil
md
usa
kit
detect
human
parainfluenza
virus
human
metapneumoviru
human
coronaviru
human
adenoviru
influenza
virus
b
human
respiratori
syncyti
viru
rsv
b
human
rhinoviru
also
analys
specimen
respiratori
virus
use
novel
polymeras
chain
pcrldr
multiplex
assay
origin
system
design
detect
influenza
virus
expand
includ
parainfluenza
coronavirus
influenza
b
rhinovirus
b
c
adenovirus
ae
metapneumoviru
rsv
b
detect
virus
includ
multiplex
system
clinic
sampl
ie
nasal
aspir
except
adenovirus
use
laboratori
posit
control
viral
sequenc
multiplex
assay
list
tabl
protein
level
ifnc
determin
use
magnet
beadbas
multiplex
immun
assay
biorad
hercul
ca
usa
interest
cc
chemokin
prompt
gene
array
result
ovalbuminsensit
challeng
mice
data
shown
ifna
ifnb
level
measur
use
standard
elisa
r
system
minneapoli
mn
usa
aspir
homogen
mrna
extract
describ
use
rneasi
rneasyplu
kit
qiagen
mrna
analys
ifna
ifnb
rigi
use
quantit
real
time
pcr
use
specif
primer
probe
signal
normal
gapdh
assess
feno
exhal
breath
day
week
child
well
least
day
viral
infect
measur
feno
employ
niox
mino
aerocrin
new
provid
nj
usa
feno
measur
influenc
diet
exercis
particip
ask
refrain
eat
drink
within
h
exhal
breath
assess
triplic
sampl
obtain
assess
reliabl
mean
standard
deviat
interquartil
rang
use
describ
measur
valu
nasal
cytokin
level
nasal
mrna
symptom
score
viral
ill
box
plot
use
repres
chang
biomark
differ
point
cold
rel
baselin
whisker
boxplot
repres
minimum
maximum
valu
distribut
continu
outcom
variabl
examin
appropri
transform
taken
achiev
normal
effect
viral
ill
defin
seegen
kit
result
biomark
protein
level
biomark
level
symptom
score
determin
use
gener
mix
model
proc
mix
autoregress
correl
structur
use
sa
statist
softwar
sa
cari
nc
usa
evalu
adjust
relev
covari
age
gender
ethnicityrac
nasal
steroid
use
potenti
explanatori
variabl
famili
incom
baselin
asthma
sever
tobacco
smoke
exposur
oral
antihistamin
use
evalu
includ
final
model
signific
predictor
mrna
outcom
except
ifnb
level
undetect
larg
number
sampl
therefor
categor
result
detectablenondetect
level
analys
binari
variabl
use
gener
estim
equat
gee
approach
tobit
link
analys
ifnb
mrna
level
continu
variabl
use
gee
approach
ident
link
unadjust
model
shown
sixteen
children
physiciandiagnos
asthma
recruit
particip
rang
age
year
old
boy
nonwhit
report
symptom
medic
use
consist
persist
asthma
tabl
particip
complet
total
week
assess
tabl
current
report
focus
week
concord
self
report
ill
viral
detect
use
seegen
kit
virusposit
sick
week
virusneg
well
week
retest
eight
posit
seven
neg
sampl
seeplex
use
pcrligat
detect
multiplex
assay
twelv
sampl
concord
two
assay
two
sampl
posit
seeplex
neg
pcrldr
one
sampl
show
rsv
seeplex
assay
coronaviru
pcrldr
symptom
score
qualit
evalu
sever
ill
rose
sick
week
fig
respiratori
symptom
highest
first
assess
sick
week
day
initi
report
ill
children
confirm
viral
ill
experienc
signific
increas
cough
wheez
chest
tight
indic
asthma
exacerb
tabl
select
nasal
aspir
cytokin
measur
use
magnet
beadbas
multiplex
immun
assay
signific
increas
cytokin
examin
week
report
symptom
singl
except
tabl
fig
pattern
strike
sampl
document
viral
infect
compar
confirm
virusneg
unadjust
estim
associ
confirm
viral
infect
cytokin
level
highli
signific
shown
chang
appreci
adjust
age
gender
race
nasal
steroid
use
chang
cytokin
cours
ill
shown
fig
case
cytokin
increas
first
day
infect
persist
throughout
week
also
examin
relationship
cytokin
symptom
score
unadjust
estim
associ
confirm
viral
infect
cytokin
level
symptom
score
signific
ifnc
tabl
cytokin
level
correl
symptom
score
also
attempt
measur
ifna
ifnb
protein
level
nasal
aspir
elisa
ifna
level
lower
detect
limit
pgml
found
five
specimen
virusposit
week
ifnb
level
detect
limit
pgml
found
sampl
five
virusneg
seven
virusposit
mani
aspir
dilut
number
specimen
show
mrna
signal
tabl
nevertheless
detect
transcript
rigi
ifna
ifnb
patient
viral
infect
could
detect
mrna
specimen
final
infect
significantli
increas
number
sampl
posit
rigi
mrna
measur
feno
virusposit
sick
week
fig
signific
chang
feno
measur
viral
infect
viral
infect
frequent
caus
asthma
attack
theori
chemokin
product
virusinfect
epitheli
cell
induc
recruit
inflammatori
cell
airway
turn
elabor
cytokin
mediat
capabl
increas
airway
respons
data
suggest
immun
cell
may
also
infect
respiratori
virus
produc
chemokin
present
studi
found
natur
cold
respiratori
tract
cytokin
level
significantli
increas
children
asthma
level
subset
cytokin
correl
degre
time
cours
respiratori
symptom
chemokin
detect
respons
recruit
broad
array
inflammatori
cell
includ
neutrophil
monocyt
macrophag
eosinophil
final
detect
chang
nasal
lavag
specimen
collect
home
repeat
basi
associ
infect
although
measur
cytokin
level
normal
subject
data
show
children
asthma
appar
capabl
robust
cytokin
respons
viral
infect
even
mild
exacerb
addit
home
collect
nasal
lavag
specimen
appear
practic
tool
studi
natur
histori
viral
infect
children
result
expand
upon
prior
work
character
cytokin
respons
detect
respiratori
secret
asthmat
associ
viral
ill
pizzichini
et
al
found
compar
day
infect
sputum
level
eosinophil
cation
protein
fibrinogen
six
adult
asthmat
significantli
elev
day
start
coldinduc
exacerb
furthermor
level
correl
number
sputum
neutrophil
teran
et
al
asthma
found
compar
asymptomat
period
level
major
basic
protein
increas
nasal
aspir
children
acut
viralinduc
exacerb
grissel
et
al
asthma
found
compar
group
stabl
asthmat
level
significantli
elev
induc
sputa
older
children
adult
suffer
acut
viralinduc
asthma
exacerb
along
neutrophil
eosinophil
also
increas
although
significantli
final
santiago
et
al
found
compar
control
sampl
increas
nasal
aspir
asthmat
children
h
upper
respiratori
tract
infect
chemokin
level
correl
macrophag
nasal
aspir
upper
respiratori
symptom
score
present
studi
patient
use
control
confirm
chang
provid
new
data
show
signific
increas
importantli
found
increas
chemokin
sustain
throughout
week
follow
viral
infect
also
examin
relationship
cytokin
respiratori
symptom
score
interestingli
found
cytokin
correl
symptom
score
ifnc
wherea
other
although
examin
lower
airway
cytokin
level
tempt
specul
former
set
cytokin
respons
acut
asthmat
respons
viral
infect
wherea
latter
set
may
modul
futur
immun
respons
base
differ
ifnb
ifnk
product
cell
isol
control
asthmat
subject
propos
patient
asthma
prone
rhinovirusinduc
exacerb
due
defici
ifn
product
hand
vitro
studi
show
differ
rhinovirusinduc
gene
express
epitheli
cell
isol
asthmat
healthi
subject
control
asthmat
subject
experiment
infect
rhinoviru
show
differ
respiratori
tract
viral
titr
copi
number
found
viral
infect
natur
cold
significantli
increas
level
ifnc
protein
ifnk
mrna
nasal
aspir
viral
infect
also
significantli
increas
express
level
rigi
induc
type
ifn
togeth
data
suggest
asthmat
children
capabl
function
ifn
respons
hand
fail
detect
ifna
ifnb
protein
nasal
aspir
signific
chang
mrna
level
natur
cold
detect
type
ifn
respiratori
secret
made
difficult
low
sensit
commerci
avail
assay
physiolog
low
level
cytokin
biolog
fluid
particularli
fluid
without
suffici
number
plasmacytoid
dendrit
cell
presenc
natur
inhibitor
eg
solubl
receptor
also
could
compar
result
experiment
subject
children
without
asthma
find
mrna
elev
respiratori
viral
infect
children
asthma
valid
recent
studi
analys
pattern
gene
express
nasal
lavag
sampl
children
experienc
picornavirusinduc
asthma
exacerb
consist
previou
work
examin
requir
rhinovirusinduc
gene
express
cultur
airway
epitheli
cell
coexpress
analysi
demonstr
major
hub
connect
ifnmedi
respons
virusinduc
asthma
exacerb
studi
pilot
new
pcrldrbase
method
respiratori
viru
detect
twelv
sampl
concord
two
viral
detect
techniqu
two
case
sampl
posit
seeplex
neg
pcrldr
precis
caus
discrep
two
test
certain
seeplex
test
reli
visual
detect
band
agaros
electrophoresi
gel
may
liabl
fals
posit
also
optim
pcrldr
test
maximum
specif
goal
avoid
fals
posit
may
result
reduct
sensit
copi
number
viral
nucleic
acid
low
measur
effect
natur
cold
feno
previou
studi
shown
feno
reliabl
measur
eosinophil
airway
inflamm
steroid
respons
clinic
control
children
adult
allerg
asthma
feno
level
also
shown
increas
emerg
steroid
treatment
acut
asthma
exacerb
contrast
found
despit
increas
airway
cytokin
respiratori
symptom
increas
feno
natur
cold
children
rel
baselin
state
data
consist
notion
airway
inflamm
context
viralinduc
asthma
exacerb
differ
charact
associ
chronic
asthma
sever
limit
studi
first
although
nasal
sampl
advantag
increas
safeti
decreas
particip
burden
sputum
specimen
close
reflect
respons
lower
airway
viral
infect
howev
note
level
ifnc
significantli
correl
respiratori
symptom
includ
lower
respiratori
tract
symptom
cough
wheez
chest
tight
short
breath
indic
asthma
exacerb
addit
previou
studi
found
similar
chang
nasal
aspir
sputum
cytokin
concentr
follow
viral
exacerb
asthma
final
observ
demonstr
consist
effect
nasal
bronchial
provoc
second
measur
inflammatori
cell
nasal
aspir
therefor
could
assess
function
effect
chemokin
releas
subject
previou
studi
shown
recruit
neutrophil
eosinophil
macrophag
respiratori
tract
follow
rhinovir
infect
asthmat
subject
also
determin
cellular
sourc
mrna
measur
studi
pilot
analysi
show
primarili
epitheli
cell
neutrophil
nasal
aspir
suggest
epitheli
cell
primari
sourc
mrna
third
note
compar
respons
asthmat
subject
control
recent
studi
show
asthmat
nonatop
subject
experi
similar
cold
includ
chemokin
respons
follow
experiment
rhinoviru
infect
fourth
although
abl
detect
signific
differ
mani
cytokin
follow
upper
respiratori
tract
infect
fraction
sampl
dilut
detect
mrna
may
reason
loss
rna
exampl
sampl
ribonucleas
dilut
may
also
affect
concentr
measur
biomark
adjust
measur
total
protein
content
vascular
leakag
due
inflamm
may
alter
protein
concentr
children
upper
respiratori
infect
experi
total
protein
difficult
measur
mani
nasal
tracheal
aspir
specimen
even
cytokin
readili
detect
therefor
normal
total
protein
increas
reliabl
concentr
final
studi
natur
occur
cold
children
use
homebas
method
inher
involv
variabl
sampl
time
handl
present
control
environ
laboratori
yet
approach
also
offer
opportun
observ
real
world
scenario
abil
detect
statist
signific
chang
specif
mrna
protein
use
current
studi
design
suggest
viabl
approach
use
futur
investig
exampl
studi
examin
whether
earli
adjust
asthma
medic
could
abort
temper
impact
respiratori
viral
infect
conclud
children
asthma
natur
occur
viral
infect
appar
induc
robust
innat
immun
respons
includ
express
specif
chemokin
ifn
ifnrespons
gene
cytokin
respons
sustain
first
week
follow
viral
infect
futur
analys
control
asthmat
combin
determin
cytokin
respons
asthma
health
outcom
provid
insight
cellular
pathway
respons
virusinduc
asthma
exacerb
